Correspondence on "Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure" by Joshi et al

Yalta K.Ozkan U.Yalta T.2024-06-122024-06-1220211355-6037https://doi.org/10.1136/heartjnl-2021-320124https://hdl.handle.net/20.500.14551/16378[No abstract available]en10.1136/heartjnl-2021-320124info:eu-repo/semantics/closedAccessCotransporter; Glucose; Sodium; Adverse Event; Heart Failure; Human; Glucose; Heart Failure; Humans; Sodium; Sodium-Glucose Transporter 2 Inhibitors; SymportersCorrespondence on "Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure" by Joshi et alLetter1072319222-s2.0-8512195764034656974Q1